- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT02153190
Hybrid Artificial Pancreas in Home Setting (AP Hybrid)
Assessment of Hybrid Use of an Artificial Pancreas in a Home Setting for Two Months in Patients With Type 1 Diabetes
연구 개요
상세 설명
연구 유형
등록 (실제)
단계
- 2 단계
연락처 및 위치
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Age ≥ 18 et < 70 years old
- Having diabetes according to WHO criteria for at least 6 months, and Type 1 diabetes according to ADA criteria
- Under basal-bolus insulin therapy using an external insulin pump for at least 3 months
- BMI < 35 kg/m²
- Willing to wear a CGM device for the whole duration of the study, except during washout period, combined with the DiAs platform during the evening and night-time for 2 months
- Trained in carbohydrate counting
- HbA1c > 7.5 % and < 10%
- If on antihypertensive, thyroid, anti-depressant or lipid lowering medication, stability on the medication for at least 1 month prior to study inclusion
- Willing to undergo all study procedures
- Informed consent signed
Exclusion criteria:
- Pregnancy or breast feeding, or intention to be pregnant during the study duration
- Use of a medication that significantly impacts glucose metabolism, e.g. steroids
- Uncontrolled hypertension with resting blood pressure over 140/90 mmHg
- Patient plans to go abroad during the trial period
- Patient is expected to be out-of-home in the evening and during night time (e.g. shift-workers, etc.) more than 25% of a study period
- Patient does not hold any nearby party for assistance if needed
- Patient with severe hypoglycemia including coma, mental confusion and/or convulsions requesting IV glucose injection or glucagon injection during the last year.
- Presence of any malignant disease, unless considered as cured for more than 10 years
- History of acute cardiovascular event during the prior year
- History of diabetic keto-acidosis during the prior 6 months
- Renal insufficiency with creatinin > 150 μmol/L
- Impairment of liver status estimated from ASAT/ALAT plasma levels > 2x upper limits of normal values
- Impaired cognitive or psychological abilities which may result in defective adherence to study conditions
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 크로스오버 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
실험적: HYBRID-OPEN
Patients are randomized on the schedule; hybrid period and after open period. During the HYBRID Period, the patient will use the AP model when at home, from dinner to wake-up time whereas the patient will self manage glucose control with insulin pump and CGM for the rest of the day. During the control period called OPEN Period, patient self management of diabetes by insulin pump and CGM will be done at all times. Overall, an increase of time spent in range when using artificial pancreas in the hybrid period should be observed with a reduction of both hypo and hyperglycemia episodes. |
During the HYBRID Period, the patient will use the AP model when at home, from dinner to wake-up time whereas the patient will self manage glucose control with insulin pump and CGM for the rest of the day.
During the control period called OPEN Period, patient self management of diabetes by insulin pump and CGM will be done at all times.
|
실험적: OPEN-HYBRID
Patients are randomized on the schedule: open period and after hybrid period. During the control period called OPEN Period, patient self management of diabetes by insulin pump and CGM will be done at all times. During the HYBRID Period, the patient will use the AP model when at home, from dinner to wake-up time whereas the patient will self manage glucose control with insulin pump and CGM for the rest of the day. Overall, an increase of time spent in range when using artificial pancreas in the hybrid period should be observed with a reduction of both hypo and hyperglycemia episodes. |
During the HYBRID Period, the patient will use the AP model when at home, from dinner to wake-up time whereas the patient will self manage glucose control with insulin pump and CGM for the rest of the day.
During the control period called OPEN Period, patient self management of diabetes by insulin pump and CGM will be done at all times.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
기간 |
---|---|
Percent time spent in target range (3.9-10.0 mmol/L or 70-180 mg/dL) during each study period
기간: during 2 months-hybrid period and during 2 months-open period
|
during 2 months-hybrid period and during 2 months-open period
|
2차 결과 측정
결과 측정 |
기간 |
---|---|
Low Blood Glucose Index (LBGI)
기간: for each period of 2 month (hybrid period and open period)
|
for each period of 2 month (hybrid period and open period)
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Eric ER RENARD, MD, University Hospital, Montpellier
간행물 및 유용한 링크
일반 간행물
- Renard E, Farret A, Kropff J, Bruttomesso D, Messori M, Place J, Visentin R, Calore R, Toffanin C, Di Palma F, Lanzola G, Magni P, Boscari F, Galasso S, Avogaro A, Keith-Hynes P, Kovatchev B, Del Favero S, Cobelli C, Magni L, DeVries JH; AP@home Consortium. Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home. Diabetes Care. 2016 Jul;39(7):1151-60. doi: 10.2337/dc16-0008. Epub 2016 May 5.
- Kropff J, Del Favero S, Place J, Toffanin C, Visentin R, Monaro M, Messori M, Di Palma F, Lanzola G, Farret A, Boscari F, Galasso S, Magni P, Avogaro A, Keith-Hynes P, Kovatchev BP, Bruttomesso D, Cobelli C, DeVries JH, Renard E, Magni L; AP@home consortium. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial. Lancet Diabetes Endocrinol. 2015 Dec;3(12):939-47. doi: 10.1016/S2213-8587(15)00335-6. Epub 2015 Sep 30.
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
1형 당뇨병에 대한 임상 시험
-
Rhythm Pharmaceuticals, Inc.완전한Pro-opiomelanocortin(POMC), Proprotein Convertase Subtilisin/Kexin Type 1(PCSK1) 및 Leptin 수용체(LepR) 유전자 돌연변이미국, 이스라엘, 캐나다, 독일, 그리스, 이탈리아, 포르투갈
HYBRID에 대한 임상 시험
-
Cairo University아직 모집하지 않음
-
Limacorporate S.p.a아직 모집하지 않음골관절염 | 류마티스 관절염 | 관절 성형술 | 무혈성 괴사 | 관절염 | 상완골 골절 | 어깨 골관절염 | 어깨 관절염 | 커프 파열 관절병증
-
University of OxfordUniversity of Cape Town; Mothers2Mothers완전한
-
University of VirginiaJuvenile Diabetes Research Foundation완전한